Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Pioneer factors – a new class of proteins

NCRI

Published: 18 Nov 2009

Views: 11402

Rating:

Save

Dr Jason Carroll, Cambridge Research Institute, UK

Dr Carroll was the winner of the BACR/AstraZeneca Frank Rose Young Scientist Award. He discusses work on understanding how pioneer factors regulate oestrogen receptor function in breast cancer cells.

Categories:
Breast

Related Videos

EBCC 2024: Addressing inequalities across Europe in access to innovation for...

Dr Fiorita Poulakaki (Athens Medical Centre Hospital, Athens, Greece) and Dr...

EBCC 2024: Addressing inequalities across Europe in access to innovation for patients with metastatic breast cancer ( Dr Fiorita Poulakaki (Athens Medical Centre Hospital, Athens, Greece) and Dr Michail Ignatiadis (Institut Jules Bordet, Brussels, Belgium) )

Comment: EBCC 2024 highlights

Dr Fiorita Poulakaki (Athens Medical Centre Hospital, Athens, Greece) andDr...

Comment: EBCC 2024 highlights ( Dr Fiorita Poulakaki (Athens Medical Centre Hospital, Athens, Greece) andDr Michail Ignatiadis (Institut Jules Bordet, Brussels, Belgium) )

Saruparib shows encouraging efficacy and safety in mutant advanced solid tumours

Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Housten, USA

Saruparib shows encouraging efficacy and safety in mutant advanced solid tumours ( Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Housten, USA )

Pembrolizumab improves breast cancer outcomes regardless of age or menopausal...

Dr Javier Cortes - International Breast Cancer Center, Barcelona, Spain

Pembrolizumab improves breast cancer outcomes regardless of age or menopausal status ( Dr Javier Cortes - International Breast Cancer Center, Barcelona, Spain )

Exercise positively effects symptom burden and quality of life of metastatic...

Dr Anouk Hiensch - UMC Utrecht, Utrecht, Netherlands

Exercise positively effects symptom burden and quality of life of metastatic breast cancer patients ( Dr Anouk Hiensch - UMC Utrecht, Utrecht, Netherlands )

Using AI to identify patients at increased risk of side effects from radiation...

Dr Tim Rattay - University of Leicester Cancer Research Centre, Leicester, UK

Using AI to identify patients at increased risk of side effects from radiation treatment for breast cancer ( Dr Tim Rattay - University of Leicester Cancer Research Centre, Leicester, UK )

Implementation of the Choosing Wisely Africa List in 3 Countries

Dr Sarah Kutika Nyagabona - Muhimbili National Hospital, Dar es Salaam, Tanzania

Implementation of the Choosing Wisely Africa List in 3 Countries ( Dr Sarah Kutika Nyagabona - Muhimbili National Hospital, Dar es Salaam, Tanzania )

Adding atezolizumab to adjuvant chemotherapy for stage II and III triple...

Dr Michail Ignatiadis - Institut Jules Bordet, Brussels, Belgium

Adding atezolizumab to adjuvant chemotherapy for stage II and III triple-negative breast cancer is unlikely to improve efficacy ( Dr Michail Ignatiadis - Institut Jules Bordet, Brussels, Belgium )

T-DM1 shows promise in treating unresectable locally advanced or metastatic...

Dr Sara Hurvitz - University of Washington, Seattle, USA

T-DM1 shows promise in treating unresectable locally advanced or metastatic HER2-positive breast cancer ( Dr Sara Hurvitz - University of Washington, Seattle, USA )

More from ecancer